{"id":"W4286294937","doi":"10.1200/jco.2022.40.16_suppl.e14017","title":"Real-world analysis of outcomes of patients receiving bevacizumab for recurrent glioblastoma in British Columbia.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Temozolomide; Demographics; Internal medicine; Proportional hazards model; Oncology; Glioblastoma; Multivariate analysis; Progression-free survival; Retrospective cohort study; Chemotherapy; Radiosurgery; Overall survival; Surgery; Radiation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078104,0.0002441106,0.000433404,0.001439996,0.0008036332,0.00113762,0.0007744653,0.0004596484,0.001576842],"category_scores_gemma":[0.003768209,0.0002319202,0.0002986447,0.003943899,0.0004113731,0.0003554813,0.0007983966,0.0005122032,0.0003573801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008746902,"about_ca_system_score_gemma":0.006162196,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7531496,"about_ca_topic_score_gemma":0.8176419,"domain_scores_codex":[0.9990078,0.0001415685,0.0001515575,0.0001907732,0.0002951643,0.0002131816],"domain_scores_gemma":[0.9947447,0.0004454561,0.002079767,0.0001708695,0.001713951,0.0008452518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002347374,0.00002391596,0.993991,0.00006475482,0.00006103807,0.0001247776,0.0001369891,0.0001142045,0.00008128561,0.00001999883,0.001523181,0.003624068],"study_design_scores_gemma":[0.00001530563,0.00004105506,0.9980003,0.00003888398,0.00003393018,0.0001665776,0.0003886396,0.000274563,0.00003864033,0.000013749,0.0009781764,0.00001007974],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853398,0.0009031927,0.00005922345,0.0002735445,0.000009372574,0.00005248057,0.0118165,0.00001256778,0.001533258],"genre_scores_gemma":[0.9922999,0.0003593208,0.0001069577,0.0001287666,0.000007894671,0.00004478125,0.006676831,0.00000555351,0.0003698654],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2468504,"threshold_uncertainty_score":0.4966082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06459525051494117,"score_gpt":0.4327033120342623,"score_spread":0.3681080615193212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}